Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.27
Delayed Data
As of Jun 27
 -0.03 / -2.31%
Today’s Change
1.13
Today|||52-Week Range
4.62
-54.24%
Year-to-Date

Today’s Trading

Previous close1.30
Today’s open1.31
Day’s range1.26 - 1.32
Volume1,652,142
Average volume (3 months)2,799,834
Market cap$172.2M
Dividend yield83.09%
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.01-0.98%
ATHXAthersys Inc-0.03-1.91%
FOMXFoamix Pharmaceutica...-0.08-1.78%
NEOSNeos Therapeutics In...-0.30-4.08%
Data as of 3:59pm ET, 06/27/2017

Financials

Next reporting dateAugust 11, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts